Organic Letters
ORCID
Letter
Balamurugan, R.; Wetzel, S.; Renner, S.; Gerauer, M.; Scholermann, B.;
̈
Rusch, M.; Kramer, J. W.; Rauh, D.; Coates, G. W.; Brunsveld, L.;
Bastiaens, P. I. H.; Waldmann, H. Nat. Chem. Biol. 2010, 6, 449.
(e) Wang, Z.; Gu, C.; Colby, T.; Shindo, T.; Balamurugan, R.;
Waldmann, H.; Kaiser, M.; van der Hoorn, R. A. Nat. Chem. Biol. 2008,
4, 557.
(6) (a) Kamat, S. S.; Camara, K.; Parsons, W. H.; Chen, D.-H.; Dix, M.
M.; Bird, T. D.; Howell, A. R.; Cravatt, B. F. Nat. Chem. Biol. 2015, 11,
164. (b) Camara, K.; Kamat, S. S.; Lasota, C. C.; Cravatt, B. F.; Howell,
A. R. Bioorg. Med. Chem. Lett. 2015, 25, 317.
Present Address
†(C.A.M.) Department of Chemistry, University of Michigan,
Ann Arbor, MI 48109.
Notes
The authors declare no competing financial interest.
(7) For selected reviews, see: (a) Nelson, S. G.; Dura, R. D.; Peelen, T.
J. Org. React. 2012, 82, 471. (b) Romo, D.; Wang, Y.; Tennyson, R. L.
Heterocycles 2004, 64, 605. (c) Pommier, A.; Pons, J. M. Synthesis 1993,
1993, 441.
(8) (a) Raju, R.; Howell, A. R. Org. Lett. 2006, 8, 2139. (b) Liang, Y.;
Raju, R.; Taylor, C. D.; Le, T.; Howell, A. R. Tetrahedron Lett. 2009, 50,
1020.
ACKNOWLEDGMENTS
■
This paper is based upon work partially supported by the
National Institutes of Health (NIH) under Grant No. R01
CA193994. Boehringer Ingelheim is acknowledged for financial
support (BI Fellowship for C.A.M.).
(9) For leading references and reviews, see: (a) Albrecht, F.; Sowada,
O.; Fistikci, M.; Boysen, M. M. K. Org. Lett. 2014, 16, 5212. (b) Edwards,
H. J.; Hargrave, J. D.; Penrose, S. D.; Frost, C. G. Chem. Soc. Rev. 2010,
39, 2093. (c) Collier, P. N. Tetrahedron Lett. 2009, 50, 3909. (d) Konno,
T.; Tanaka, T.; Miyabe, T.; Morigaki, A.; Ishihara, T. Tetrahedron Lett.
2008, 49, 2106. (e) Fagnou, K.; Lautens, M. Chem. Rev. 2003, 103, 169.
(f) Hayashi, T.; Yamasaki, K. Chem. Rev. 2003, 103, 2829.
REFERENCES
■
(1) For reviews related to biological activity of β-lactones, see:
(a) Groll, M.; Korotkov, V. S.; Huber, E. M.; de Meijere, A.; Ludwig, A.
Angew. Chem., Int. Ed. 2015, 54, 7810. (b) Yang, P.-Y.; Liu, K.; Zhang, C.;
Chen, G. Y. J.; Shen, Y.; Ngai, M. H.; Lear, M. J.; Yao, S. Q. Chem. - Asian
J. 2011, 6, 2762. (c) Kluge, A. F.; Petter, R. C. Curr. Opin. Chem. Biol.
2010, 14, 421.
(2) For leading references and reviews, see: (a) Chandra, S.; Jyothi, M.;
Raghu, M. R. P. WJPPS 2015, 4, 448. (b) Kumar, P.; Dubey, K. K. RSC
Adv. 2015, 5, 86954. (c) Wei, K.; Wang, G.-Q.; Bai, X.; Niu, Y.-F.; Chen,
H.-P.; Wen, C.-N.; Li, Z.-H.; Dong, Z.-J.; Zui, Z.-L.; Xiong, W.-Y.; Liu, J.-
K. Nat. Prod. Bioprospect. 2015, 5, 129.
(3) For leading references and reviews, see: (a) Zhu, M.; Harshbarger,
W. D.; Robles, O.; Krysiak, J.; Hull, K. G.; Cho, S. W.; Richardson, R. D.;
Yang, Y.; Garcia, A.; Spiegelman, L.; Ramirez, B.; Wilson, C. T.; Yau, J.
A.; Moore, J. T.; Walker, C. B.; Sacchettini, J. C.; Liu, W. R.; Sieber, S. A.;
Smith, J. W.; Romo, D. Bioorg. Med. Chem. 2017, 25, 2901. (b) Gill, K.
A.; Berrue, F.; Arens, J. C.; Carr, G.; Kerr, R. G. J. Nat. Prod. 2015, 78,
822. (c) Harvey, M. L.; Krysiak, J.; Chamni, S.; Cho, S. W.; Sieber, S. A.;
Romo, D. Chem. - Eur. J. 2015, 21, 1425. (d) List, A.; Zeiler, E.;
Gallastegui, N.; Rusch, M.; Hedberg, C.; Sieber, S. A.; Groll, M. Angew.
Chem., Int. Ed. 2014, 53, 571. (e) Tekkam, S.; Alam, M. A.; Just, M. J.;
Berry, S. M.; Johnson, J. L.; Jonnalagadda, S. C.; Mereddy, V. R. Anti-
Cancer Agents Med. Chem. 2013, 13, 1514. (f) Wustrow, D.; Zhou, H.-J.;
Rolfe, M. Annu. Rep. Med. Chem. 2013, 48, 205. (g) Richardson, R. D.;
Ma, G.; Oyola, Y.; Zancanella, M.; Knowles, L. M.; Cieplak, P.; Romo,
D.; Smith, J. W. J. Med. Chem. 2008, 51, 5285. (h) Yoshida, K.;
Yamaguchi, K.; Sone, T.; Unno, Y.; Asai, A.; Yokosawa, H.; Matsuda, A.;
Arisawa, M.; Shuto, S. Org. Lett. 2008, 10, 3571. (i) Kridel, S. J.; Axelrod,
F.; Rozenkrantz, N.; Smith, J. W. Cancer Res. 2004, 64, 2070.
(j) Knowles, L. M.; Axelrod, F.; Browne, C. D.; Smith, J. W. J. Biol.
Chem. 2004, 279, 30540. (k) Feling, R. H.; Buchanan, G. O.; Mincer, T.
J.; Kauffman, C. A.; Jensen, P. R.; Fenical, W. Angew. Chem., Int. Ed.
2003, 42, 355. (l) Corey, E. J.; Li, W.-D. Z. Chem. Pharm. Bull. 1999, 47,
1.
(10) (a) Croix, C.; Prie,
Chem. 2015, 80, 3264. (b) Allen, J. C.; Kociok-Kohn, G.; Frost, C. G.
Org. Biomol. Chem. 2012, 10, 32. (c) Navarro, C.; Moreno, A.; Csaky, A.
́
̈
́
G.; Chaulet, C.; Viaud-Massuard, M.-C. J. Org.
̈
G. J. Org. Chem. 2009, 74, 466. (d) De Risi, C.; Fanton, G.; Pollini, G. P.;
Trapella, C.; Valente, F.; Zanirato, V. Tetrahedron: Asymmetry 2008, 19,
131. (e) Shintani, R.; Duan, W. L.; Hayashi, T. J. Am. Chem. Soc. 2006,
128, 5628. (f) Hargrave, J. D.; Bish, G.; Frost, C. G. Chem. Commun.
2006, 4389. (g) Chen, G.; Tokunaga, N.; Hayashi, T. Org. Lett. 2005, 7,
2285. (h) Shintani, R.; Ueyama, K.; Yamada, I.; Hayashi, T. Org. Lett.
2004, 6, 3425.
(11) (a) Zou, G.; Guo, J.; Wang, Z.; Huang, W.; Tang, J. Dalton Trans.
2007, 3055. (b) Zou, G.; Wang, Z.; Zhu, J.; Tang, J. Chem. Commun.
2003, 2438.
(12) Based on 1H NMR analysis of the crude reaction mixture.
(13) The relative stereochemistry was deduced based on a
combination of comparison of spectral data to known compounds
and trends seen from previous work (ref 6b) for coupling constants and
relative chemical shifts for trans/cis isomers.
(14) For additional leading references for the synthesis of trans-β-
lactones, see: (a) Mulzer, M.; Coates, G. W. J. Org. Chem. 2014, 79,
11851. (b) Meier, P.; Broghammer, F.; Latendorf, K.; Rauhut, G.; Peters,
R. Molecules 2012, 17, 7121. (c) Zhao, C.; Mitchell, A. T.; Vallakati, R.;
́
Perez, L. M.; Romo, D. J. Am. Chem. Soc. 2012, 134, 3084.
(15) Ponzano, S.; Bertozzi, F.; Mengatto, L.; Dionisi, M.; Armirotti, A.;
Romeo, E.; Berteotti, A.; Fiorelli, C.; Tarozzo, G.; Reggiani, A.; Duranti,
A.; Tarzia, G.; Mor, M.; Cavalli, A.; Piomelli, D.; Bandiera, T. J. Med.
Chem. 2013, 56, 6917. (b) Purohit, V. C.; Richardson, R. D.; Smith, J.
W.; Romo, D. J. Org. Chem. 2006, 71, 4549.
(16) Mikami, Y.; Yazawa, Y.; Tanaka, Y.; Ritzau, M.; Grafe, U. Nat.
Prod. Lett. 1999, 13, 277.
(17) For total syntheses of nocardiolactones, see: (a) Kumaraswamy,
G.; Markondaiah, B. Tetrahedron 2008, 64, 5861. (b) Sun, Y.-P.; Wu, Y.
Synlett 2005, 1477.
(4) For leading references and reviews, see: (a) Wu, G.; Zhang, Z.;
Chen, H.; Lin, K. Bioorg. Med. Chem. Lett. 2015, 25, 2345. (b) Weinandy,
F.; Lorenz-Baath, K.; Korotkov, V. S.; Bottcher, T.; Sethi, S.;
Chakraborty, T.; Sieber, S. A. ChemMedChem 2014, 9, 710.
(c) Compton, C. L.; Schmitz, K. R.; Sauer, R. T.; Sello, J. K. ACS
Chem. Biol. 2013, 8, 2669. (d) De Pascale, G.; Nazi, I.; Harrison, P. H.
̈
(18) (a) Malapit, C. A.; Caldwell, D. R.; Sassu, N.; Milbin, S.; Howell,
A. R. Org. Lett. 2017, 19, 1966. (b) Adam, W.; Groer, P.; Saha-Moller, C.
̈
M.; Wright, G. D. J. Antibiot. 2011, 64, 483. (e) Bottcher, T.; Sieber, S. A.
̈
R. Tetrahedron: Asymmetry 1997, 8, 833.
Angew. Chem., Int. Ed. 2008, 47, 4600. (f) Wells, J. S.; Trejo, W. H.;
Principe, P. A.; Sykes, R. B. J. Antibiot. 1984, 37, 802. (g) Tymiak, A. A.;
Culver, C. A.; Malley, M. F.; Gougoutas, J. Z. J. Org. Chem. 1985, 50,
5491. (h) Pu, Y.; Lowe, C.; Sailer, M.; Vederas, J. C. J. Org. Chem. 1994,
59, 3642.
(5) For leading references and reviews, see: (a) Davda, D.; Martin, B. R.
MedChemComm 2014, 5, 268. (b) Lajkiewicz, N. J.; Cognetta, A. B., III;
Niphakis, M. J.; Cravatt, B. F.; Porco, J. A., Jr. J. Am. Chem. Soc. 2014,
(19) Martínez, I.; Andrews, A. E.; Emch, J. D.; Ndakala, A. J.; Wang, J.;
Howell, A. R. Org. Lett. 2003, 5, 399.
(20) (a) Navarre, L.; Darses, S.; Genet, J.-P. Adv. Synth. Catal. 2006,
348, 317. (b) Navarre, L.; Darses, S.; Genet, J.-P. Chem. Commun. 2004,
1108.
136, 2659. (c) Bottcher, T.; Sieber, S. A. MedChemComm 2012, 3, 408.
̈
(d) Dekker, F. J.; Rocks, O.; Vartak, N.; Menninger, S.; Hedberg, C.;
D
Org. Lett. XXXX, XXX, XXX−XXX